Preview

PULMONOLOGIYA

Advanced search

Effect of power inhaler design on drug deposition in the respiratory tract

Abstract

Disodium chromoglycate particles were labelled with pure gamma-radiator, 99m Tc, using the co-precipitation technique based on spray drying. Radioactive drug particles were mixed, with lactose carrier and filled into hard gelatin capsules. Seven healthy volunteers inhaled drug doses using Spinhaler, I. S. F., Berotec, and Rotahaler dry powder devices. The fractional deposition of drug particles in the upper airways and lung region were monitored using a gamma camera. The fraction of the dose relained in the powder inhaler was the smallest for I. S. F. and especially for Berotec inhalers. These devices have narrower air channel constructions with a smaller wall surface area than the Spinhaler and Rotahaler devices. Thus the sticking of the drug particles onto the plastic walls was less probable for the first mentioned devices. The drug particles from all the dry powder inhalers seemed to be more able to follow the inspired air stream without depositing in the upper airways than previously documented for pressurized metered dose aerosols. I. S. F. and Berotec inhalers with narrow air channels gave the greatest lung deposition of the inhaled drug, particles. Thus the design of the dry powder inhaler was noticed to have a remark able effect both on the emptying of the capsules as well as on the redispersion of the powder mixture.

About the Authors

M. Vidgren
Университет Куопио; Центральная клиника Университета Куопио
Finland


A. Karkainen
Университет Куопио; Центральная клиника Университета Куопио
Finland


P. Karjalainen
Университет Куопио; Центральная клиника Университета Куопио
Finland


P. Paronen
Университет Куопио; Центральная клиника Университета Куопио
Finland


J. Nuutinen
Университет Куопио; Центральная клиника Университета Куопио
Finland


References

1. Barrow G. М. Physical Chemistry.—Tokyo, 1973.—P. 534.

2. Bell J. H., Hartley P. S., Cox I. S. G. / / J. Pharm . Sei.1971.—Vol. 60.—P. 1559—1564.

3. Boner A. L., Niero E., Grigolini C. et al. / / Europ. J. resp. Dis.—1985.—Vol. 66.—P. 21—24.

4. Byron P. R. / / Drug Develop. Ind. Pharm .—1986.Vol. 12.—P. 993—1015.

5. Cocozza S., Inhaler for powdered medicaments, U. S. Pat. N 3, 991, 761 (1976).

6. Crompton C. G. Europ. J. resp. Dis.—1982.—Vol. 63.— P. 101 —104.

7. Davies P. J., Hanlon G. W., Molyneux A. J . / / J. Pharm . Pharmacol.—1976.—Vol. 28.—P. 908—911.

8. Harris R., Rothwell R. P. G. / / N. Z. med. J .—1981.Vol. 94.—P. 421—425.

9. Hetzet M. R., Clark T. J. H. / / Clin. Allergy.—1977.Vol. 7.—P. 563—566.

10. Moren F., Anderson J. / / Int. J. Pharmacol.—1980.Vol. 6.—P. 295—300.

11. Moren F., Newhause М. Т., Dolovich М. B. Aerosols in Medicine—Principles, Diagnosis and Therapy.—Amsterdam , 1985.—P. 265.

12. Newman S. P., Pavia D., Moren F., et al. / / Thorax.1981.—Vol. 36.—P. 52—55.

13. Power G. M., Dash C. H. / / Pharmacotherapeutica .1985.—Vol. 4.—P. 98—100.

14. Steil E. Inhalator for pulverulent substances, U. S. Pat. No 3, 918, 451 (1975).

15. Vidgren M., Kärkkäineti A., Karjalainen P., Paronen P. / / Int. J. Pharmacol.—1987.—Vol. 37.—P. 239—244.

16. Vidgren М., Paronen P., Karkkainen A., Karjalainen P. / / Ibid .- P. 107—112.

17. Vidgren М., Karkkainen A., Paronen P., Karjalainen P. / / Ibid.—P. 101—105.


Review

For citations:


Vidgren M., Karkainen A., Karjalainen P., Paronen P., Nuutinen J. Effect of power inhaler design on drug deposition in the respiratory tract. PULMONOLOGIYA. 1991;(4):26-30. (In Russ.)

Views: 119


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)